AstraZeneca Pharma India receives permission for sale and distribution of Trastuzumab deruxtecan
The receipt of this permission paves way for the launch of Trastuzumab deruxtecan (Enhertu) solution of 100mg/5mL in India
The receipt of this permission paves way for the launch of Trastuzumab deruxtecan (Enhertu) solution of 100mg/5mL in India
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
Sun Pharma said had a teleconference call with the US Food and Drug Administration (USFDA) regarding a pulmonary embolism (serious adverse events) occurring at the 12 mg dose
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
The partnership will capitalize on the combined capabilities of the two organizations
Subscribe To Our Newsletter & Stay Updated